Skip to content

Efficacy of post-operative pain management with intralesional ropivacaine after subacromial decompression

Efficacy of post-operative pain management with intralesional ropivacaine after subacromial decompression - Pain management after subacromial decompression.

Status
Active, not recruiting
Phases
Phase 3
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON34278
Enrollment
189
Registered
2012-01-03
Start date
2010-10-01
Completion date
Unknown
Last updated
2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

not enough space in the shoulder subacromial impingement

Interventions

None listed

Sponsors

Ziekenhuisgroep Twente
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Patients (18 years and older) with subacromial impingement syndrome who need a subacromial decompression by dr. C. van Doorn

Exclusion criteria

Exclusion criteria: Significant damage at the affected shoulder or untreatable subacromial impingement a history of injury at the affected shoulder a history of surgery at the affected shoulder a history of mastectomy at the affected side a neuropathologic condition at the affected shoulder chonic use of opioids extraordinary risk-increasing factors, like morbid obesity Parkinsons disease pregnancy contraindications for the used medications disability which leads to an inability to describe pain and inability to fill in the VAS score. not understand written and/or spoken Dutch

Design outcomes

Primary

MeasureTime frame
Pain perception of the patient just after surgery and on certain moments afterwards, set on a VAS score.

Secondary

MeasureTime frame
The amount of escape medication used by the patient and the calculated costs of the postoperative pain management.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)